RALIAT ODEWALE: Open Payments
NPI 1629854146 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $194 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $64 |
| Gilead Sciences, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Indivior Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Wegovy, Epclusa, AIRSUPRA, SUBLOCADE, Veozah, ABILIFY ASIMTUFII, MOUNJARO, JARDIANCE.
Industry payments across MD — which companies pay providers there.
